115 related articles for article (PubMed ID: 1953529)
1. Chronic myeloid leukaemia treated by allogeneic bone marrow transplantation from histocompatible sibling donors--an invariably fatal malignancy rendered highly curable.
Szer J; Sheridan WP
Aust N Z J Med; 1991 Aug; 21(4):408-13. PubMed ID: 1953529
[TBL] [Abstract][Full Text] [Related]
2. Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation.
Atkinson K; Downs K; Dodds A; Concannon A; Milliken S
Aust N Z J Med; 1996 Feb; 26(1):54-8. PubMed ID: 8775529
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Chinese patients with chronic myeloid leukaemia (CML) underwent allogeneic bone-marrow transplantation (BMT).
Lee CK; Lie AK; Liang R; Au WY; Chen FE; Chim CS; Kwong YL
Am J Hematol; 1999 Jun; 61(2):85-9. PubMed ID: 10367784
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia.
Reiter E; Greinix HT; Keil F; Brugger S; Rabitsch W; Schulenburg A; Mannhalter C; Schwarzinger I; Worel N; Volc-Platzer B; Fischer G; Dieckmann K; Hinterberger W; Schneider B; Haas OA; Geissler K; Kalhs P
Ann Hematol; 1999 Nov; 78(11):507-13. PubMed ID: 10602894
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
[TBL] [Abstract][Full Text] [Related]
8. HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.
Marks DI; Hughes TP; Szydlo R; Kelly S; Cullis JO; Schwarer AP; Mackinnon S; Apperley J; Barrett AJ; Hows JM
Br J Haematol; 1992 Jul; 81(3):383-90. PubMed ID: 1390211
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT).
Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte JP; Brinch L; Cook G; Deliliers GL; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A
Br J Haematol; 1996 Dec; 95(4):715-23. PubMed ID: 8982051
[TBL] [Abstract][Full Text] [Related]
10. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
Sehn LH; Alyea EP; Weller E; Canning C; Lee S; Ritz J; Antin JH; Soiffer RJ
J Clin Oncol; 1999 Feb; 17(2):561-8. PubMed ID: 10080600
[TBL] [Abstract][Full Text] [Related]
11. Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation.
Jabro G; Koc Y; Boyle T; Schenkein DP; Ravalese J; Wazer D; Miller KB
Biol Blood Marrow Transplant; 1999; 5(3):173-9. PubMed ID: 10392963
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors.
Mackinnon S; Hows JM; Goldman JM; Arthur CK; Hughes T; Apperley JF; Jones L; Batchelor JR; Brookes P; Catovsky D
Exp Hematol; 1990 Jun; 18(5):421-5. PubMed ID: 2338131
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
14. Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults.
Barker JN; Davies SM; DeFor TE; Burns LJ; McGlave PB; Miller JS; Weisdorf DJ
Br J Haematol; 2002 Jul; 118(1):101-7. PubMed ID: 12100132
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation for chronic myeloid leukaemia.
Goldman JM
Leukemia; 1992; 6 Suppl 2():22-3. PubMed ID: 1578936
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.
Bishop MR; Henslee-Downey PJ; Anderson JR; Romond EH; Marciniak E; Yankey R; Reeves M; Thompson JS
Bone Marrow Transplant; 1996 Oct; 18(4):747-53. PubMed ID: 8899190
[TBL] [Abstract][Full Text] [Related]
17. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
18. The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Hermans J; Labopin M; Apperley J; Gorin NC; Gratwohl A
Leuk Lymphoma; 1996 Dec; 24(1-2):71-9. PubMed ID: 9049963
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow transplantation from unrelated donors in chronic myeloid leukemia: the results in 15 patients].
Sierra J; Carreras E; Rovira M; Batlle M; Urbano-Ispizua A; Marín P; Besson I; Merino A; Algara M; Cervantes F
Med Clin (Barc); 1995 May; 104(18):689-94. PubMed ID: 7769878
[TBL] [Abstract][Full Text] [Related]
20. Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning.
Cullis JO; Schwarer AP; Hughes TP; Hows JM; Franklin I; Morgenstern G; Goldman JM
Br J Haematol; 1992 Jan; 80(1):33-9. PubMed ID: 1536808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
